Skip to main content

Advertisement

SpringerLink
Log in

Current status of the epidemiology of heart failure

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Epidemiologic investigation of the evolution of heart failure in the general population has provided clues to its pathogenesis, predisposing conditions, predictive modifiable risk factors, and indicators of deteriorating ventricular function. It is a major and growing problem because of the increased size of aging populations and the prolongation of the lives of cardiac patients by modern therapy. Susceptible persons must be detected early so that preventive measures can be started because the mortality rate once overt heart failure appears is unacceptably high despite recent innovations in treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Garg R, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on morbidity and mortality in patients with heart failure: collaborative group on ACE-Inhibitor Trials. JAMA 1995, 273:1450–1456.

    Article  PubMed  CAS  Google Scholar 

  2. Cowie MR, Mosterd A, Wood DA, et al.: The epidemiology of heart failure. Eur Heart J 1997, 18:208–225.

    PubMed  CAS  Google Scholar 

  3. Hoes AW, Mosterd A, Grobbe DE: An epidemic of heart failure? Eur Heart J 1998, 19(suppl L):L2-L8.

    PubMed  Google Scholar 

  4. Bonneux L, Barendregt JJ, Meeter K, et al.: Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 1994, 84:20–28.

    Article  PubMed  CAS  Google Scholar 

  5. Colquhoun MC, Waine C, Monaghan MJ, et al.: Investigation in general practice of patients with suspected heart failure. How should the essential echocardiographic service be delivered? Br Heart J 1995, 74:335–336.

    PubMed  CAS  Google Scholar 

  6. Graves EG, Gillum BS: 1994 Summary: National Hospital Discharge Survey: advance data. National Center for Health Statistics 1999, 278:1–12.

    Google Scholar 

  7. Cleland LGF, Erdmann E, Ferrari R, et al.:Guidelines for the diagnosis of heart failure. Eur Heart J 1995, 16: 741–751.

    Google Scholar 

  8. Brown AM, Cleland JGF: Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. Eur Heart J 1998, 19:1063–1069.

    Article  PubMed  CAS  Google Scholar 

  9. McMurray J, McDonough T, Morrison CE, et al.: Trends for hospitalization for heart failure in Scotland 1980–1990. Eur Heart J 1993, 14:1158–1162.

    PubMed  CAS  Google Scholar 

  10. Garg R, Packer M, Pitt B, Yusuf S: Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol 1993, 22(suppl A):3A-5A.

    Article  PubMed  CAS  Google Scholar 

  11. Heart and Stroke: Statistical Update. Dallas: American Heart Association; 1997.

  12. Konstam M, Dracup K, Baker D, et al.: Heart Failure: Evaluation and Care of Patients with Left Ventricular Systolic Dysfunction [Clinical Practice Guideline No. 11, AHCPR publication no. 94-0612]. In Rockville, MD:Agency for Health Care Policy and Research; 1994.

    Google Scholar 

  13. Byrns RB, McCarthy EP, Moskowitz MA, et al.: Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc 1997, 45:276–280.

    Google Scholar 

  14. Mosterd A, Deckers JW, Hoes AW, et al.: Classification of heart failure in population-based research; an assessment of six heart failure scores. Eur J Epidemiol 1997, 13:491–502.

    Article  PubMed  CAS  Google Scholar 

  15. McDonough TA, Morrison CE, Lawrence A, et al: Symptomatic and asymptomatic left-ventricular dysfunction in an urban population. Lancet 1997, 350:829–833.

    Article  Google Scholar 

  16. Gardin JM, Siskovick D, Culver H, et al.: Sex, age and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly: the Cardiovascular Health study. Circulation 1995, 91;1734–1748.

    Google Scholar 

  17. Lauer MS, Evans JC, Levy D: Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease: the Framingham Heart Study. Am J Cardiol 1992, 70:1180–1184.

    Article  PubMed  CAS  Google Scholar 

  18. Vasan RS, Benjamin EJ, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565–1574.

    Article  PubMed  CAS  Google Scholar 

  19. Ho KKL, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993, 22:6A-13A.

    Article  PubMed  CAS  Google Scholar 

  20. Massie BM, Shah NB: Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997, 133:703–712.

    Article  PubMed  CAS  Google Scholar 

  21. Rich MW: Epidemiology, pathophysiology and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997, 45:968–974.

    PubMed  CAS  Google Scholar 

  22. Ho KKL, Anderson KM, Kannel WB, et al.: Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993, 88:107–115.

    PubMed  CAS  Google Scholar 

  23. Schocken DD, Arrieta MI, Leaverton PE: Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992, 20:301–306.

    Article  PubMed  CAS  Google Scholar 

  24. Data Fact Sheet: Congestive Heart Failure in the United States: A New Epidemic. Bethesda: National Heart Lung and Blood Institute Information Center; 1999.

  25. Morbidity and Mortality Chartbook on Cardiovascular, Lung and Blood Diseases. Bethesda: National Heart Lung and Blood Institute; 1999.

  26. Brophy JM: Epidemiology of congestive heart failure: Canadian data from 1970–1989. Can J Cardiol 1992, 8:495–498.

    PubMed  CAS  Google Scholar 

  27. Anderson B, Waagstein F: Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993, 126:632–640.

    Article  Google Scholar 

  28. Rhahimtoola SH, Cheitlin MD, Hutter AM: Valvular and congenital heart disease. J Am Coll Cardiol 1987, 10(suppl A):60A-62A.

    Article  Google Scholar 

  29. Gillum RF: Idiopathic cardiomyopathy in the United States, 1970–1982. Am Heart J 1986, 111: 752–755.

    Article  PubMed  CAS  Google Scholar 

  30. Levy D, Larson MG, Vasan RS, et al.: The progression from hypertension to congestive heart failure. JAMA 1999, 275:1557–1562.

    Article  Google Scholar 

  31. Kannel WB: Need and prospects for prevention of cardiac failure. Eur J Clin Pharm 1999, 49:S3-S9.

    Google Scholar 

  32. Wilhelmsen L: Cardiothoracic ratio and the relative heart volume as predictors of coronary heart disease mortality. Eur Heart J 1998, 19:826–827.

    PubMed  CAS  Google Scholar 

  33. Yamamoto K, Burnett JC, Jougaski M, et al.: Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1999, 28:988–994.

    Google Scholar 

  34. McMurray JV, McDonagh TA, Davie AP, et al.: Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 1998, 19:842–846.

    PubMed  CAS  Google Scholar 

  35. Kannel WB, D'Agostino RB, Silbershatz H, et al.: Profile for estimating risk of heart failure. Arch Intern Med 1999, in press.

  36. Heidenreich PA, Lee TT, Massie BM: Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997, 30:27–34.

    Article  PubMed  CAS  Google Scholar 

  37. Kannel WB, Ho K, Thom T: Changing epidemiological features of cardiac failure. Br Heart J 1994, 72(suppl):S3-S9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Framingham Study of the National Heart Lung and Blood Institute and Boston University, Boston, MA, USA

    W. B. Kannel MD

Authors
  1. W. B. Kannel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kannel, W.B. Current status of the epidemiology of heart failure. Curr Cardiol Rep 1, 11–19 (1999). https://doi.org/10.1007/s11886-999-0035-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-999-0035-7

Keywords

Search

Navigation